The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

In the Sutent monotherapy arm, patients whose disease progressed may be eligible ... and grade 3 anemia, weakness and peripheral edema. All three patients’ serious side effects were possibly ...

in the Xofigo arm vs the placebo arm, respectively, were nausea (36% vs 35%), diarrhea (25% vs 15%), vomiting (19% vs 14%), and peripheral edema (13% vs 10%). Grade 3 and 4 adverse events were ...

Three days before the current presentation, dysesthesia progressed to involve the trunk and arms, and headache developed ... lorazepam was administered. A peripheral intravenous catheter was ...

The decision to discontinue the doxazosin arm of the antihypertensive trial ... This is of particular concern since peripheral edema was one of the several criteria employed to reach the diagnosis ...

“These stockings help patients with peripheral edema—lower leg ... causing swelling (AKA edema), most commonly in the arms or legs—higher compression levels may be necessary under medical ...

hypothermia in the elderly in cold houses) or peripheral circulation problems such as trench ... degrees The person may be curled up in a fetal position. Try to open their arm up from the fetal ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...